2026. SPECTRUM AND SEVERITY OF ADVERSE DRUG REACTIONS DURING TREATMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS. International Research Journal of Pharmacy. 17, 9 (Sep. 2026), 11–17. DOI:https://doi.org/10.56802/cyzkpf46.